The tweet was deleted by the author.
But we saved everything 🙂.
OptimizeRx draws attention to the dual impact of artificial intelligence, cautioning that while optimization can boost efficiency, it carries the risk of shrinking your audience if not managed strategically.
Mike Rousselle of OptimizeRx emphasizes that AI should not only refine existing demand but also help create new opportunities, echoing insights shared via Newsweek. The company advises decision makers to approach AI deployment with a broader perspective to maximize reach and innovation.
OptimizeRx previously highlighted that up to 30% of direct-to-consumer audiences can be lost during onboarding due to identity fragmentation and measurement gaps. The company has also discussed how AI and opt-in technologies are shaping patient-centric marketing in pharma, ahead of MM+M Transform in New York. These developments frame ongoing concerns about balancing efficiency and audience reach as AI strategies evolve.